{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:00Z","timestamp":1793276940169,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["FI20\/00184"],"award-info":[{"award-number":["FI20\/00184"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PI22\/00556"],"award-info":[{"award-number":["PI22\/00556"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["PI19\/00083"],"award-info":[{"award-number":["PI19\/00083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031651","name":"Centro Nacional de Investigaciones Oncol\u00f3gicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031651","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.modpat.2024.100551","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:44:52Z","timestamp":1719319492000},"page":"100551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Victoria","family":"Men\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Cos\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cereceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Montalb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arutha","family":"Kulasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-0806","authenticated-orcid":false,"given":"Juan F.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2033433","article-title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: characterizing CD4+ T cells in Hodgkin lymphoma","volume":"11","author":"Veldman","year":"2022","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.modpat.2024.100551_bib2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cancers14051360","article-title":"The Hodgkin lymphoma immune microenvironment: turning bad news into good","volume":"14","author":"Men\u00e9ndez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2024.100551_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.890410","article-title":"Challenges and opportunities for immunoprofiling using a spatial high-plex technology: The NanoString GeoMx\u00ae Digital Spatial Profiler","volume":"12","author":"Hernandez","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100551_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.modpat.2024.100551_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","article-title":"Methods and applications for single-cell and spatial multi-omics","volume":"24","author":"Vandereyken","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad1026","article-title":"standR: spatial transcriptomic analysis for GeoMx DSP data","volume":"52","author":"Liu","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12885-019-5927-3","article-title":"Estimation of immune cell content in tumor using single-cell RNA-seq reference data","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Cancer"},{"issue":"27","key":"10.1016\/j.modpat.2024.100551_bib8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2024.100551_bib9","article-title":"DTL Is a prognostic biomarker and promotes bladder cancer progression through regulating the AKT\/mTOR axis","author":"Luo","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"21","key":"10.1016\/j.modpat.2024.100551_bib10","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.3390\/ijms20215503","article-title":"Immune and inflammatory cells of the tumor microenvironment represent novel therapeutic targets in classical hodgkin lymphoma","volume":"20","author":"Calabretta","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.modpat.2024.100551_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2024.100551_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/10428194.2016.1239263","article-title":"The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy","volume":"58","author":"Alonso-\u00c1lvarez","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.modpat.2024.100551_bib13","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","article-title":"Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells","volume":"122","author":"Greaves","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100551_bib14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-020-1006-1","article-title":"A\u00a0peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma","volume":"26","author":"Cader","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"issue":"7","key":"10.1016\/j.modpat.2024.100551_bib16","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3324\/haematol.2011.055459","article-title":"Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma","volume":"97","author":"S\u00e1nchez-Espiridi\u00f3n","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2024.100551_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/path.1711220205","article-title":"Rosetting and other reactions of the Reed-Sternberg cell","volume":"122","author":"Stuart","year":"1977","journal-title":"J\u00a0Pathol"},{"issue":"21","key":"10.1016\/j.modpat.2024.100551_bib18","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.2020005546","article-title":"Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58","volume":"136","author":"Veldman","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100551_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00428-023-03562-1","article-title":"Digital spatial profiling of CD4+ T cells in classic Hodgkin lymphoma","volume":"483","author":"Takeuchi","year":"2023","journal-title":"Virchows Arch"},{"issue":"19","key":"10.1016\/j.modpat.2024.100551_bib20","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100551_bib21","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.146.9.3242","article-title":"Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes","volume":"146","author":"Lancki","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100551_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41385-021-00427-1","article-title":"Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells","volume":"14","author":"Hoek","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41598-024-51376-1","article-title":"Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma","volume":"14","author":"Men\u00e9ndez","year":"2024","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.modpat.2024.100551_bib24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.modpat.2024.100551_bib25","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the Multicohort Single-Arm Phase II CheckMate 205 Trial","volume":"36","author":"Armand","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.modpat.2024.100551_bib26","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2024.100551_bib27","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100551_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ajpath.2012.05.015","article-title":"CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications","volume":"181","author":"Anderson","year":"2012","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100551_bib29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/0008-5472.CAN-12-3849","article-title":"Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression","volume":"73","author":"Ho","year":"2013","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2024.100551_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1160188","article-title":"CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth","volume":"5","author":"Rajendran","year":"2016","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.modpat.2024.100551_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100551_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40259-022-00573-3","article-title":"Targeting co-stimulatory receptors of the TNF superfamily for cancer immunotherapy","volume":"37","author":"M\u00fcller","year":"2023","journal-title":"BioDrugs"},{"issue":"23","key":"10.1016\/j.modpat.2024.100551_bib33","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease","volume":"28","author":"van Rhee","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100551_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910576","article-title":"The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma","volume":"11","author":"Hashwah","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.modpat.2024.100551_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/698313","article-title":"Interleukin 6 and rheumatoid arthritis","author":"Yoshida","year":"2014","journal-title":"Biomed Res Int"},{"issue":"9617","key":"10.1016\/j.modpat.2024.100551_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.modpat.2024.100551_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/10428199209049781","article-title":"Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors","volume":"7","author":"Tesch","year":"1992","journal-title":"Leuk Lymphoma"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:58:43Z","timestamp":1778695123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0893395224001315"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100551","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100551"}}